Wakamoto Pharmaceutical Co's quarterly market cap
increased
from Dec. 2023 (円7,393 Mil) to Mar. 2024 (円7,844 Mil) and
increased
from Mar. 2024 (円7,844 Mil) to Sep. 2024 (円9,197 Mil).
Wakamoto Pharmaceutical Co's annual market cap
declined
from Mar. 2022 (円10,030 Mil) to Mar. 2023 (円8,573 Mil) and
declined
from Mar. 2023 (円8,573 Mil) to Mar. 2024 (円7,844 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Wakamoto Pharmaceutical Co's Enterprise Value for Today is 円7,310 Mil.
Wakamoto Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Wakamoto Pharmaceutical Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Wakamoto Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wakamoto Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Wakamoto Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Wakamoto Pharmaceutical Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wakamoto Pharmaceutical Co (TSE:4512) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Wakamoto Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of Wakamoto Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4512 has been successfully added to your 